22 completed. 22 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 22 | Completed 22 |
Follow ipragliflozin: new trials by email Literature Review of ipragliflozin trials Research Report on ipragliflozin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Compare the Oral Absorption of ASP1941 Among Two Types of Tablets ASP1941 - Healthy, Plasma Concentration of ASP1941 | Phase 1 | Completed | Astellas Pharma Inc | 32 | 2013-09-01 | 2014-02-07 |
| A Phase 1 Study to Investigate the Mechanism of Action of Ipragliflozin ASP1941, Placebo - Type 2 Diabetes Mellitus | Phase 1 | Completed | Astellas Pharma Europe B.V. | 44 | 2011-10-27 | 2017-08-22 |
| Drug to Drug Interaction Study With Ipragliflozin and Furosemide Ipragliflozin, Furosemide - Healthy Subjects, Pharmacokinetics of Ipragliflozin | Phase 1 | Completed | Astellas Pharma Europe B.V. | 24 | 2011-07-01 | 2012-06-05 |
| Absolute Bioavailability Study With Ipragliflozin Ipragliflozin - Bioavailability of Ipragliflozin, Healthy Subjects | Phase 1 | Completed | Astellas Pharma Europe B.V. | 14 | 2011-06-01 | 2012-06-05 |
| A Study to Assess the Effect of ASP1941 and Mitiglinide on Their Plasma Concentration ASP1941, Mitiglinide calcium hydrate - Healthy, Pharmacokinetics of ASP1941 | Phase 1 | Completed | Astellas Pharma Inc | 60 | 2011-06-01 | 2011-10-12 |
| A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of ASP1941 in Healthy Male Taiwanese Subjects ASP1941, Placebo - Healthy, Pharmacokinetics of ASP1941 | Phase 1 | Completed | Astellas Pharma Inc | 56 | 2011-02-01 | 2011-10-12 |
| A Study to Investigate the Effect of Food on the Absorption, Distribution and Elimination of ASP1941 ASP1941 - Healthy, Pharmacokinetics of ASP1941 | Phase 1 | Completed | Astellas Pharma Inc | 30 | 2010-10-01 | 2012-08-29 |
| A Study of the Effect of ASP1941 on Cardiac Repolarization in Healthy Subjects Placebo, ASP1941, Moxifloxacin - Healthy Subjects, Cardiac Repolarization | Phase 1 | Completed | Astellas Pharma Inc | 88 | 2010-09-01 | 2011-02-28 |
| A Study to Assess the Effect of Hepatic Function on the Pharmacokinetics and Safety of ASP1941 ASP1941 - Liver Disease | Phase 1 | Completed | Astellas Pharma Inc | 16 | 2010-05-01 | 2010-10-07 |
| A Study to Assess the Pharmacokinetics, Pharmacodynamics of ASP1941 in Diabetes Mellitus Patients With Renal Impairment ASP1941 - Type 2 Diabetes Mellitus | Phase 1 | Completed | Astellas Pharma Inc | 25 | 2010-02-16 | 2024-11-12 |
| A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Sitagliptin When Given Together to Healthy Subjects ASP1941, sitagliptin - Healthy, Pharmacokinetics of ASP1941 | Phase 1 | Completed | Astellas Pharma Inc | 64 | 2010-02-01 | 2010-04-16 |
| A Study to Assess Drug-Drug Interaction Between ASP1941 and Miglitol ASP1941, Miglitol - Healthy Volunteers, Pharmacokinetics of ASP1941 | Phase 1 | Completed | Astellas Pharma Inc | 30 | 2010-02-01 | 2010-06-09 |
| Renal Impairment Study With ASP1941 ASP1941 - Type 2 Diabetes Mellitus | Phase 1 | Completed | Astellas Pharma Inc | 40 | 2010-01-22 | 2017-08-22 |
| Drug-drug Interaction Study With ASP1941 and Glimepiride ASP1941, Glimepiride - Healthy Subjects | Phase 1 | Completed | Astellas Pharma Inc | 52 | 2009-12-01 | 2011-02-23 |
| A Study of ASP1941 in Japanese Patients With Type 2 Diabetes Mellitus ASP1941, Placebo - Type 2 Diabetes Mellitus | Phase 1 | Completed | Astellas Pharma Inc | 30 | 2009-11-07 | 2024-11-12 |
| A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Pioglitazone Hydrochloride When Given Together to Healthy Subjects ASP1941, pioglitazone hydrochloride - Healthy, Pharmacokinetics of ASP1941 | Phase 1 | Completed | Astellas Pharma Inc | 64 | 2009-11-01 | 2010-04-16 |
| Drug to Drug Interaction Study With ASP1941 and Metformin ASP1941, Metformin, Placebo - Type 2 Diabetes Mellitus | Phase 1 | Completed | Astellas Pharma Inc | 36 | 2009-02-25 | 2017-07-28 |
| Mass Balance Study of ASP1941 ASP1941 - Healthy Subjects | Phase 1 | Completed | Astellas Pharma Inc | 6 | 2008-05-01 | 2011-02-23 |
| Study of the Pharmacokinetics of ASP1941 and the Effect on Glucose Concentrations in Male and Female Young and Elderly Healthy Adults ASP1941, Placebo - Healthy Volunteers, Pharmacokinetics of ASP1941 | Phase 1 | Completed | Astellas Pharma Global Development, Inc. | 65 | 2007-11-01 | 2012-09-05 |
| Multiple Dose Escalating Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1941 ASP1941, Placebo - Healthy | Phase 1 | Completed | Astellas Pharma Inc | 48 | 2007-05-01 | 2011-02-03 |
Showing 20 of 22. Sign in to see all of them.
Diabetes Mellitus (5) · Diabetes Mellitus, Type 2 (5) · Glycosuria (1) · Liver Diseases (1) · Renal Insufficiency (1)
Astellas Pharma Inc (18) · Astellas Pharma Europe B.V. (3) · Astellas Pharma Global Development, Inc. (1)
Japan (7) · United States (5) · Netherlands (4) · United Kingdom (3) · Hungary (2) · Poland (2) · Slovakia (2) · Czechia (1) · Germany (1) · Taiwan (1)
PMID 21877761, PMID 22795925, PMID 23359360, PMID 23910665, PMID 32839028
2009 (2), 2008 (1)